Advertisement
Screener

Design Therapeutics, Inc. (DSGN) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Design Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where Design Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $54.36M went out.
  • Fiscal year ended 2025-12-31: from investing, $22.91M came in.
  • Fiscal year ended 2025-12-31: from financing, $25.74M came in.
  • Fiscal year ended 2025-12-31: change in cash, $5.71M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$54.36M$22.91M$24.85M$891.00K*-$5.71M
2024-12-31-$43.10M$43.95M$0.00$513.00K*$1.36M
2023-12-31-$58.56M$52.54M$419.00K-$5.30M
2022-12-31-$51.32M-$220.99M$323.00K-$272.07M
2021-12-31-$29.38M-$53.64M$34.00K$379.18M*$296.19M
2020-12-31-$8.67M-$33.56M$1.00K$44.53M*$2.30M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$15.52M*$15.06M*$0.00*$605.00K*
2026-03-31-$16.43M-$7.59M$19.91M-$4.09M
2025-12-31-$11.97M*-$11.58M*$182.00K*$25.14M*
2025-09-30-$11.16M*$6.51M*$37.00K*
2025-06-30-$14.44M*$20.12M*$0.00*
2025-03-31-$16.79M$7.87M$0.00-$8.90M
2024-12-31-$9.86M*$1.83M*$9.00K*
2024-09-30-$9.55M*-$5.83M*$1.00K*
2024-06-30-$11.26M*$27.33M*$6.00K*
2024-03-31-$12.44M$20.62M$20.00K$8.20M
2023-12-31-$12.80M*$5.55M*$402.00K*
2023-09-30-$14.53M*$15.27M*$13.00K*
2023-06-30-$13.80M*$11.98M*
2023-03-31-$17.42M$19.73M$2.31M
2022-12-31-$15.09M*-$1.06M*$16.00K*
2022-09-30-$13.90M*-$63.39M*$151.00K*
2022-06-30-$10.50M*-$156.96M*$0.00*
2022-03-31-$11.83M$414.00K$156.00K-$11.26M
2021-12-31-$9.23M*-$50.06M*-$1.00K*
2021-09-30-$8.16M*-$5.04M*$30.00K*
2021-06-30-$8.29M*-$21.57M*
2021-03-31-$3.70M$23.03M$378.98M*$398.31M
2020-12-31-$2.84M*$2.00M*
2020-09-30-$1.86M*$3.19M*
2020-06-30-$1.31M*$501.00K*
2020-03-31-$2.66M-$39.25M$44.53M*$2.63M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Faeth Therapeutics, Inc. (FTH)United States$0.750B
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
GERON CORP (GERN)United States$0.803B-12.14
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53